Condition: ANCA Associated Vasculitis (AAV) · Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
The primary aim is to study the efficacy of treatment with BDB-001 Injection to induce remission in patients with active anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), when used in combination with cyclophosphamide followed by azathioprine, or in combination with rituximab
This description comes directly from the study's public registry record.
Aiping Sun · +86 010-67519614 · sunaiping@staidson.com
Always discuss trial participation with your own doctor first.
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking University International Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Tsinghua Changgung Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking University First Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Xiamen University | Xiamen, Fujian, China | Not Yet Recruiting |
| The First Hospital of Lanzhou University | Lanzhou, Gansu, China | Not Yet Recruiting |
| Guangdong General Hospital | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Sun Yat-sen Memorial Hospital of Sun Yat-sen University | Guangzhou, Guangdong, China | Not Yet Recruiting |
+ 53 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07168161